Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates

Toxicological Sciences

Volumn 54, Issue 1, 2000, Pages 30-41

  Bammler, Theo K ^a   Slone, Dennis H ^a   Eaton, David L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aflatoxin B1; Chemoprevention; Cytochrome P450; Ethoxyquin; Glutathione S transferase; Oltipraz; Primates

Indexed keywords

AFLATOXIN B1; ANTIOXIDANT; EPOXIDE; ETHOXYQUIN; GLUTATHIONE PEROXIDASE; OLTIPRAZ;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; DIETARY INTAKE; DNA ADDUCT; DRUG TRANSFORMATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIMATE; RAT; RODENT; SPECIES DIFFERENTIATION;

ANIMALIA; CALLITHRIX JACCHUS; MACACA; MACACA NEMESTRINA; MARMOSETS; PRIMATES; RODENTIA;

EID: 0034118377     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/54.1.30     Document Type: Article

References (52)

1. Austwick, P. K. C., and Ayerst, G. (1963). Toxic products in groundnuts: Groundnut microflora and toxicity. Chem. Ind. Lon. 2, 55-61.
2. Bechtel, D. H. (1989). Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: Linear correlation with hepatic cancer risk. Regul. Toxicol. Pharmacol. 10, 74-81.
3. Beland, F. A., Dooley, K. L., and Casciano, D. A. (1979). Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J. Chromatogr. 174, 177-186.
4. Bogaards, J. J., Verhagen, H., Willems, M. I., van-Poppel, G., and van-Bladeren, P. J. (1994). Consumption of Brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma. Carcinogenesis 15, 1073-1075.
5. 1 biotransformation. Toxicol. Lett. 58, 97-105.
6. Bressac, B., Kew, M., Wands, J., and Ozturk, M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429-431.
7. 1 biotransformation in rat liver: Implications for human chemointervention. Cancer Res. 56, 2306-2313.
8. Buetler, T. M., and Eaton, D. L. (1992). Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues. Cancer Res. 52, 314-318.
9. Buetler, T. M., Slone, D., and Eaton-D. L. (1992). Comparison of the aflatoxin B1-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat. Biochem. Biophys. Res. Commun. 188, 597-603.
10. 1 in rats. Cancer. Lett. 19, 125-132.
11. 1 in cultured mouse hepatocytes: Comparison with rat and effects of cyclohexene oxide and diethyl maleate. Toxicol. Appl. Pharmacol. 50, 429-436.
12. Degen, G. H.,and Neumann, H. G. (1981). Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide. Carcinogenesis 2, 299-306.
13. Eaton, D. L., and Gallagher, E. P. (1994). Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34, 135-172.
14. Egner, P. A., Gange, S. J., Dolan, P. M., Groopman, J. D., Munoz, A., and Kensler, T. W. (1995). Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis 16, 1769-1773.
15. 1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141, 595-606.
16. 1. Cancer Res. 54, 101-108.
17. Gupta, E., Olopade, O. I., Ratain, M. J., Mick, R., Baker, T. M., Berezin, F. K., Benson, A. B., and Dolan, M. E. (1995). Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin. Cancer Res. 1, 1133-1138.
18. Hayes, J. D., Judah, D. J., McLellan, L. I., and Neal, G. E. (1991). Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. Pharmacol. Ther. 50, 443-472.
19. 1 is associated with the expression of a novel aldo-keto reductase, which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res. 53, 3887-3894.
20. Hayes, J. D., Judah, D. J., Neal, G. E., and Nguyen, T. (1992). Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem. J. 285, 173-180.
21. 1. J. Biol. Chem. 269, 20707-20717.
22. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 350, 427-428.
23. 1 aldehyde reductase. Biochem. J. 332, 21-34.
24. Iyer, R. S., Coles, B. F., Raney, K. D., Thier, R., Guengerich, F. P., and Harris T. M. (1994). DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies. J. Am. Chem. Soc. 116, 1603-1609.
25. Johnson, W. W., Harris, T. M., and Guengerich, F. P. (1996). Kinetics and mechanism of hydrolysis of aflatoxin B-1 exo-8,9-epoxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc. 118, 8213-8220.
26. 1-8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase. Chem. Res. Toxicol. 10, 672-676.
27. 1-induced genotoxicity in yeast co-expressing human CYP1A enzymes. Toxicologist 48, 315.
28. Kensler, T. W., Egner, P. A., Davidson, N. E., Roebuck, B. D., Pikul, A., and Groopman, J. D. (1986). Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer Res. 46, 3924-3931.
29. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D., and Roebuck, B. D. (1987). Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47, 4271-4277.
30. Kensler, T. W., He, X., Otieno, M., Egner, P. A., Jacobson, L. P., Chen, B. B., Wang, J.-S., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Fang, X., Li, Y.-F., Yu, L.-Y., Prochaska, H. J., Davidson, N. E., Gordon, G. B., Gorman, M. B., Zarba, A., Enger, C., Munoz, A., Helzlsouer, K. J. Groopman, J. D. (1998). Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev. 7, 127-134.
31. 1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Carcinogenesis 20, 1215-1223.
32. 1 metabolism in human hepatocytes in primary culture.Cancer Res. 55, 5574-5579.
33. Massey, T. E., Stewart, A. K., Daniels, J. M., and Liu, L. (1995). Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc. Soc. Exp. Biol. Med. 208, 213-217.
34. 1. Proc. Natl. Acad. Sci. USA 92, 2384-2387.
35. McLean, M., and Dutton, M. F. (1995). Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther. 65, 163-192.
36. Monroe, D. H., and Eaton, D. L. (1987). Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Toxicol. Appl. Pharmacol. 90, 401-409.
37. Monroe, D. H., and Eaton, D. L. (1988). Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse. Toxicol. Appl. Pharmacol. 94, 118-127.
38. 1 by human liver. Biochem. Pharmacol. 34, 3193-3197.
39. 1. Chem. Biol. Interact. 55, 139-155.
40. Newberne, P. M., and Butler, W. H. (1969). Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review. Cancer Res. 29, 236-250.
41. Nijhoff, W. A., Grubben, M. J., Nagengast, F. M., Jansen, J. B., Verhagen, H., van Poppel, G., and Peters, W. H. (1995). Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans. Carcinogenesis 16, 2125-2128.
42. O'Dwyer, P. J., Johnson, S. W., Khater, C., Krueger, A., Matsumoto, Y., Hamilton, T. C., and Yao, K. S. (1997). The chemopreventive agent oltipraz stimulates repair of damaged DNA. Cancer Res. 57, 1050-1053.
43. Ozturk, M., Bressac, B., Puisieux, A., Kew, M., Volmann, M., Bozcall, S., Mura, J. B., de la Monte, S., Carlson, R., Blum, H., Wands, J., Takahashi, H., von Weizsacker, F., Galun, E., Kar, S., Carr, B. I., Schroder, C. H., Erken, E., Varinli, S., Rustgi, V. K., Prat, J., Toda, G., Koch, H. K., Liang, X. H., Tang, Z.-Y., Shouval., D., Lee, H.-S., Vyas, G. N., and Sarosi, I. (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338, 1356-1359.
44. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer. Epidemiol. Biomarkers Prev. 3, 3-10.
45. 1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes. Toxicol. Appl. Pharmacol. 108, 436-447.
46. Raney, K. D., Coles, B., Guengerich, F. P., and Harris, T. M. (1992a). The endo-8,9-epoxide of aflatoxin B1 : A new metabolite. Chem. Res. Toxicol. 5, 333-335.
47. 1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5, 470-478.
48. Raney, K. D., Shimada, T., Kim, D. H., Groopman, J. D., Harris, T. M., and Guengerich, F. P. (1992c). Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: Significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Chem. Res. Toxicol. 5, 202-210.
49. Sabbioni, G., Skipper, P. L., Buchi, G., and Tannenbaum, S. R. (1987). Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 8, 819-824.
50. Sabbioni, G., and Wild, C. P. (1991). Identification of an aflatoxin G1-serum albumin adduct and its relevance to the measurement of human exposure to aflatoxins. Carcinogenesis 12, 97-103.
51. 1-epoxide and other substrates. Pharmacogenetics 5, 224-233.
52. 1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst. 91, 347-354.